Sökning: WFRF:(Hagen Chris) > Long-term patient s...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04379naa a2200469 4500 | |
001 | oai:lup.lub.lu.se:3fa26551-91f8-417d-8cf6-99c30beb11e4 | |
003 | SwePub | |
008 | 160401s2011 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/18766272 URI |
024 | 7 | a https://doi.org/10.1136/ard.2010.1377782 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Flossmann, Oliver4 aut |
245 | 1 0 | a Long-term patient survival in ANCA-associated vasculitis |
264 | c 2010-11-24 | |
264 | 1 | b BMJ,c 2011 |
520 | a Background Wegener's granulomatosis and microscopic polyangiitis are antineutrophil cytoplasm antibodies (ANCA)-associated vasculitides with significant morbidity and mortality. The long-term survival of patients with ANCA associated vasculitis treated with current regimens is uncertain. Objective To describe the long-term patient survival and possible prognostic factors at presentation in an international, multicentre, prospectively recruited representative patient cohort who were treated according to strictly defined protocols at presentation and included the full spectrum of ANCA-associated vasculitis disease. Methods Outcome data were collected for 535 patients who had been recruited at the time of diagnosis to four randomised controlled trials between 1995 and 2002. Trial eligibility was defined by disease severity and extent, covered the spectrum of severity of ANCA-associated vasculitis and used consistent diagnostic criteria. Demographic, clinical and laboratory parameters at trial entry were tested as potential prognostic factors in multivariable models. Results The median duration of follow-up was 5.2 years and 133 (25%) deaths were recorded. Compared with an age-and sex-matched general population there was a mortality ratio of 2.6 (95% CI 2.2 to 3.1). Main causes of death within the first year were infection (48%) and active vasculitis (19%). After the first year the major causes of death were cardiovascular disease (26%), malignancy (22%) and infection (20%). Multivariable analysis showed an estimated glomerular filtration rate <15 ml/min, advancing age, higher Birmingham Vasculitis Activity Score, lower haemoglobin and higher white cell count were significant negative prognostic factors for patient survival. Conclusion Patients with ANCA-associated vasculitis treated with conventional regimens are at increased risk of death compared with an age-and sex-matched population. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng |
700 | 1 | a Berden, Annelies4 aut |
700 | 1 | a de Groot, Kirsten4 aut |
700 | 1 | a Hagen, Chris4 aut |
700 | 1 | a Harper, Lorraine4 aut |
700 | 1 | a Heijl, Carolineu Lund University,Lunds universitet,Njurmedicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Nephrology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)med-clh |
700 | 1 | a Höglund, Peteru Lund University,Lunds universitet,Avdelningen för klinisk kemi och farmakologi,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Chemistry and Pharmacology,Department of Laboratory Medicine,Faculty of Medicine4 aut0 (Swepub:lu)kfar-pho |
700 | 1 | a Jayne, David4 aut |
700 | 1 | a Luqmani, Raashid4 aut |
700 | 1 | a Mahr, Alfred4 aut |
700 | 1 | a Mukhtyar, Chetan4 aut |
700 | 1 | a Pusey, Charles4 aut |
700 | 1 | a Rasmussen, Niels4 aut |
700 | 1 | a Stegeman, Coen4 aut |
700 | 1 | a Walsh, Michael4 aut |
700 | 1 | a Westman, Kerstinu Lund University,Lunds universitet,Njurmedicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Nephrology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)njur-kwe |
710 | 2 | a Njurmedicinb Sektion II4 org |
773 | 0 | t Annals of the Rheumatic Diseasesd : BMJg 70:3, s. 488-494q 70:3<488-494x 1468-2060x 0003-4967 |
856 | 4 | u http://dx.doi.org/10.1136/ard.2010.137778y FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/1876627 |
856 | 4 8 | u https://doi.org/10.1136/ard.2010.137778 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.